New cancer immunotherapy fails in first Roche trial - Reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GT32CGLJXVLRNMIRT2NJ6L4ZNM.jpg)
3/30/2022 12:00:00 AM3 years 1 month ago
A highly anticipated new cancer immunotherapy by Roche <a href="https://www.reuters.com/companies/ROG.S" target="_blank">(ROG.S)</a> failed to slow the progression of an aggressive form of lung cancer, the Swiss drug maker said on Wednesday, boding ill for a …
March 30 (Reuters) - A highly anticipated new cancer immunotherapy by Roche (ROG.S) failed to slow the progression of an aggressive form of lung cancer, the Swiss drug maker said on Wednesday, boding… [+3056 chars]
full article...